Analysis of cost-effectiveness for four kinds drugs in the treatment of acute cerebral infraction

VernacularTitle:四种药物治疗急性脑梗死的成本-效果分析
Author: Chunfang FAN ; Xuyi CHEN ; Jin LIANG
Publication Type:Journal Article
Keywords: Brain Infarction; Drug Therapy; Costs and Cost Analysis
From: Chinese Journal of Primary Medicine and Pharmacy 2014;(21):3209-3211
CountryChina
Language:Chinese
Abstract: Objective To evaluate the treatment of acute cerebral infarction of 4 kinds of drug cost-effective-ness.Methods A retrospective analysis was performed on 207 patients with acute cerebral infarction,according to the drug formulation of patients treatment,they were divided into four groups: group A (alprostadil),group B(Oza-grel),group C(Dan red injection),group D(Xuesaitong),the curative effects and adverse reactions were observed and analyzed by using pharmacoeconomic cost-effectiveness method.Results The costs of groups A,B,C and D were 5 248.6,4 253.7,4 475.8,3 501.2 yuan,respectively;The effective rates were 92.2%,83.7%,87.5%,76.9%, respectively;The cost effectiveness ratio(C/E) were 56.93,50.82,51.15,45.53,respectively;A,B,C group compared with the incremental cost-D group,the effect of ratio(△C/△E) were 107.2,110.7,91.9;The incidence of adverse reactions were 3.9%,6.1%,12.5%,11.5%.Conclusion Alprostadil group scheme was the best treatment scheme.